Topics

BIA Separations to support production of AveXis' gene therapy pipeline

07:40 EDT 29 Jul 2019 | EPM Magazine

Biochromatography manufacturing company BIA Separations has announced a collaboration with biotech company AveXis to support the manufacturing processes of Novartis’ gene therapy pipeline.

Original Article: BIA Separations to support production of AveXis' gene therapy pipeline

NEXT ARTICLE

More From BioPortfolio on "BIA Separations to support production of AveXis' gene therapy pipeline"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...